CRISPR Insider™

CRISPR News and Information from Around The World

Your Daily Pharma Scoop: Crispr On Hold, AstraZeneca Stumbles Again, TherapeuticsMD Receives FDA Approval

Posted by btwatson on June 1, 2018 4:17 am
Tags:
Categories: Crispr Articles

Source: Your Daily Pharma Scoop: Crispr On Hold, AstraZeneca Stumbles Again, TherapeuticsMD Receives FDA Approval

[unable to retrieve full-text content]

  1. Your Daily Pharma Scoop: Crispr On Hold, AstraZeneca Stumbles Again, TherapeuticsMD Receives FDA Approval  Seeking Alpha
  2. Gene-Therapy Company Crispr Drops as FDA Puts Trial on Hold  Bloomberg
  3. FDA halts one of the first human CRISPR studies before it begins  MIT Technology Review
  4. CRISPR Therapeutics and Vertex Provide Update on FDA Review of Investigational New Drug Application for CTX001 …  GlobeNewswire (press release)
  5. Full coverage

Published at Thu, 31 May 2018 22:00:32 +0000

< CRISPR Insider™ home

Crispr News

  • Intellia Therapeutics: A Leader in CRISPR/Cas9 Genome Editing ... - Best Stocks
    April 2, 2023
  • CRISPR Therapeutics AG (NASDAQ:CRSP) CEO Samarth Kulkarni ... - MarketBeat
    April 1, 2023
  • Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics - The Motley Fool
    April 1, 2023
  • Pediatric Cancer Cell Atlas Uncovers Clues About Cancer Drivers ... - GenomeWeb
    March 31, 2023
  • Quiescent Ovarian Cancer Cells Secrete Follistatin to Induce ... - Cancer Discovery
    March 31, 2023
  • Scribe Therapeutics to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Days - Yahoo Finance
    March 31, 2023
  • This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market ... - Nasdaq
    March 31, 2023
  • Genome-wide tiled detection of circulating Mycobacterium ... - Nature.com
    March 31, 2023
  • 5 Bargain-Basement Stocks to Buy Right Now - Nasdaq
    March 31, 2023
  • Buy Crispr Therapeutics On Approval Odds (NASDAQ:CRSP) - Seeking Alpha
    March 31, 2023
  • Opportunity in the CRISPR Gene Editing Market | High Market ... - Medgadget
    March 31, 2023
  • CRISPR cats and dogs? Royal Society for the Prevention of Cruelty ... - Genetic Literacy Project
    March 31, 2023
  • CRISPR pioneer Jennifer Doudna to speak April 4 in Chicago - Northwestern Now
    March 31, 2023
  • Brassinosteroid gene regulatory networks at cellular resolution in ... - Science
    March 30, 2023
  • CRISPR editing in the lung with novel lipids - Nature.com
    March 30, 2023
  • CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
    CRISPR rivals put patents aside to help in fight against Covid-19 – STAT
  • CRISPR 2.0: Base Editing in the Groove – Genetic Engineering & Biotechnology News
  • The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
    The Promises of CRISPR Genome Editing in Biomedicine – Labiotech.eu
  • The Code Breaker and Crispr People — the ethics of editing humanity – Financial Times
  • ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
    ERS Genomics Licenses CRISPR Patents to CRO ZeClinics – GenomeWeb
  • The Dark Side of CRISPR – Scientific American
    The Dark Side of CRISPR – Scientific American
  • ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
    ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement – BioSpace
  • Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
    Scientists Use CRISPR To Create Model of AML Progression – AJMC.com Managed Markets Network
  • DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
    DECODR app identifies DNA mutations from CRISPR gene therapies – European Pharmaceutical Review
  • CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
    CRISPR/Cas technology as a promising weapon to combat viral infections – Wiley
  • Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
    Neanderthal-like ‘mini-brains’ created in lab with CRISPR – Nature.com
  • Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
    Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – Phys.org
  • Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
    Affordable CRISPR app reveals unintended mutations at site of CRISPR gene repair – EurekAlert
  • New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
    New CRISPR tech targets human genome’s complex code: Programmable CRISPR/Cas9-based kinase offers insights into, control over regulatory histone proteins – Science Daily
  • After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
    After ditching Editas, AbbVie taps Caribou for new CRISPR, CAR-T pact – FierceBiotech
  • Load more [+]

Copyright 2020 CrisprInsider.com